Shopping Cart
- Remove All
- Your shopping cart is currently empty
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active, and selective inverse agonist for RORγt with an IC50 of 63.8 nM, exhibiting improved drug-like properties[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $48 | In Stock | |
5 mg | $118 | In Stock | |
10 mg | $188 | In Stock | |
25 mg | $328 | In Stock | |
50 mg | $467 | In Stock | |
100 mg | $636 | In Stock | |
200 mg | $857 | In Stock | |
1 mL x 10 mM (in DMSO) | $133 | In Stock |
Description | RORγt inverse agonist 13 (Compound 3i) is a potent, orally active, and selective inverse agonist for RORγt with an IC50 of 63.8 nM, exhibiting improved drug-like properties[1]. |
Targets&IC50 | RORγ:63.8 nM |
In vitro | RORγt inverse agonist 13 (Compound 3i) demonstrates 76% inhibition at 0.3 μM in the Th17 cell differentiation assay[1]. |
In vivo | RORγt inverse agonist 13 (Compound 3i, 25 mg/kg, orally, twice daily) demonstrates an excellent in vivo PK profile and good efficacy in an IMQ-induced psoriasis mouse model[1]. |
Molecular Weight | 513.29 |
Formula | C23H17Cl2F3N2O4 |
Cas No. | 2170477-75-3 |
Smiles | OC(=O)Cc1ccc(CNC(=O)Nc2cc(Cl)c(c(Cl)c2)-c2ccccc2OC(F)(F)F)cc1 |
Relative Density. | 1.470 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 10 mg/mL (19.48 mM), Sonication is recommended. ![]() | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.